| Chiusura precedente | 73,76 |
| Aperto | 74,38 |
| Denaro | 73,95 x 1300 |
| Lettera | 74,00 x 1400 |
| Min-Max giorno | 73,01 - 75,39 |
| Intervallo di 52 settimane | 12,47 - 95,21 |
| Volume | 8.771.437 |
| Media Volume | 26.784.592 |
| Capitalizzazione | 27,508B |
| Beta (5 anni mensile) | N/D |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -1,39 |
| Prossima data utili | 04 nov 2020 - 09 nov 2020 |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 94,15 |
- FX Empire
Moderna Receives Additional $472 Million from BARDA for COVID-19 Vaccine; Target Price $90
Moderna Inc said that the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA) has committed an additional $472 million in funding to support scaling up of manufacturing and clinical development of its novel coronavirus vaccine.
- FX Empire
Top COVID Play Moderna Reverses After Hitting All-Time High
Moderna rallied strongly overnight after a Phase 1 drug trial showed promising results in the battle against COVID-19.
- FX Empire
U.S. Stocks Set To Open Higher On Vaccine Hopes
S&P; 500 futures are up in premarket trading as traders bet that the world will have a vaccine for COVID-19 this year.
© 2020 Verizon Media. Tutti i diritti riservati.
